(Q33968273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

The anti-ischemic potential of angiotensin-converting enzyme inhibition: insights from the heart outcomes prevention evaluation trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

B Pitt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

7 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

IV9-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

8 November 2019

cites work

1 reference

12 December 2020

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

12 December 2020

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet

1 reference

12 December 2020

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigat

1 reference

12 December 2020

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

12 December 2020

Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT)

1 reference

12 December 2020

Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

1 reference

12 December 2020

Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats

1 reference

12 December 2020

Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.

1 reference

12 December 2020

Evidence-based medicine and ACE inhibition

1 reference

12 December 2020

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

12 December 2020

Effect of ACE inhibition on myocardial ischaemia

1 reference

12 December 2020

The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA).

1 reference

12 December 2020

Regression of left ventricular hypertrophy in patients with hypertension: blockade of the renin-angiotensin-aldosterone system

1 reference

12 December 2020

Overview of angiotensin II-receptor antagonists

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960230704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10894450%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

10894450

1 reference